J Korean Med Sci.  2018 May;33(21):e102. 10.3346/jkms.2018.33.e102.

Serial Changes of Cytokines in Children with Cerebral Palsy Who Received Intravenous Granulocyte-colony Stimulating Factor Followed by Autologous Mobilized Peripheral Blood Mononuclear Cells

Affiliations
  • 1Department of Translational Medicine, Graduate School of Biomedical Science & Engineering, Hanyang University, Seoul, Korea. cord@hanyang.ac.kr
  • 2Blood and Marrow Transplantation Center, Hanyang University Medical Center, Seoul, Korea.
  • 3Department of Pediatrics, Hanyang University Medical Center, Seoul, Korea.
  • 4Department of Pediatrics, Hanyang University Medical Center, Guri Hospital, Guri, Korea.
  • 5Department of Rehabilitation Medicine, Hanyang University Medical Center, Seoul, Korea.

Abstract

BACKGROUND
This study was performed to assess serial cytokine changes and their clinical impact in children with cerebral palsy (CP) who received granulocyte-colony stimulating factor (G-CSF) followed by infusion of autologous mobilized peripheral blood mononuclear cells (mPBMCs).
METHODS
Peripheral blood (PB) samples were collected from 16 CP children at enrollment, and 1 month and 7 months after G-CSF infusion as well as at the end of the study. Cytokine levels were measured by enzyme-linked immunosorbent assays with plasma samples.
RESULTS
There were no significant differences in cytokine levels between the mPBMC and placebo groups over 6 months. However, when clinical responders and non-responders were compared, interleukin (IL)-6 (P = 0.050) as well as G-CSF (P = 0.010) were higher in the responders than the non-responders at 1 month, while brain-derived neurotrophic factor (BDNF) (P = 0.030) and insulin-like growth factor (IGF)-1 (P = 0.001) were lower. In addition, BDNF was higher at baseline in the responders than the non-responders (P = 0.030).
CONCLUSION
The changes of G-CSF itself, as well as G-CSF-induced cytokines such as IL-6, may be associated with the clinical improvement of neurologic functions. The G-CSF-induced changes of IL-6, BDNF and IGF-1, and BDNF levels before treatment, could be used as prognostic factors in G-CSF trials in CP children.

Keyword

Cytokines; Granulocyte-colony Stimulating Factor (G-CSF); Peripheral Blood Mononuclear Cells; Cerebral Palsy

MeSH Terms

Brain-Derived Neurotrophic Factor
Cerebral Palsy*
Child*
Cytokines*
Enzyme-Linked Immunosorbent Assay
Granulocyte Colony-Stimulating Factor
Humans
Insulin-Like Growth Factor I
Interleukin-6
Interleukins
Plasma
Brain-Derived Neurotrophic Factor
Cytokines
Granulocyte Colony-Stimulating Factor
Insulin-Like Growth Factor I
Interleukin-6
Interleukins
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr